Ruqi Chang

Ruqi Chang

Auto-generated profile, based on publicly available information

Ruqi Chang

Microbiota Laboratory, Clinical Division of Microbiota, Department of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2018 in Oncology Letters
Verified
Journal Article
Open access
PDF file
LTLinglin Tian
Linglin Tian
YLYuan Li
Yuan Li
RCRuqi Chang
Ruqi Chang
PZPeng Zhang
Peng Zhang
JZJian Zhang
Jian Zhang
LHLijuan Huo
Lijuan Huo
Colorectal cancer caused by inflammatory bowel disease is referred as colitis‑associated cancer (CAC). The mechanism underling CAC is not fully understood. In the present study, the role of interleukin‑9 (IL‑9) in CAC was examined. The current study included 12 colorectal tissue specimens and matched adjacent tissues from CAC. The expression of IL‑9 protein was examined using immunohistochemical staining. The expression of IL‑9 in cancer tissues was markedly higher compared with that in adjacent tissues. Furthermore, IL‑9 gene overexpression lentiviral vectors were constructed to overexpress IL‑9 in RKO and Caco‑2 cell lines. The role of IL‑9 in cell proliferation was investigated using a Cell Counting Kit‑8 assay, and MYC proto‑oncogene bHLH transcription factor (c‑Myc) and cyclinD1 expression levels were detected by reverse transcription‑quantitative polymerase chain reaction. Notably, IL‑9 overexpression promoted the proliferation of colonic epithelial cells by upregulating of the expression of c‑Myc and cyclinD1. In conclusion, the present results suggested that IL‑9 may exhibit an essential role in the pathogenesis of CAC, and IL‑9 promotes the proliferation of colonic epithelial RKO and Caco2 cells, partially via the upregulation of c‑Myc and cyclinD1 expression.

22 April 2025 in mSystems
Verified
Journal Article
Open access
GZGuanzhou Zhou
Guanzhou Zhou
JHJiabin Hu
Jiabin Hu
MXMengqi Xu
Mengqi Xu
YLYiyuan Li
Yiyuan Li
RCRuqi Chang
Ruqi Chang
YYYunsheng Yang
Yunsheng Yang
Honeybees ( Apis mellifera ), as social insects, exhibit complex social behaviors and cognitive functions. The short lifespan and stable gut microorganisms of honeybees provide certain availability as a rapid and high-flux animal model for aging research. This study explored the effect of D-galactose, a common aging inducer, on honeybees and investigated the associated effects and mechanisms, with particular focus on the potential protective role of sodium butyrate. Experimental cohorts were established as follows: conventional (CV) group, D-galactose-treated (DG) group, and sodium butyrate-treated (SB) group. The CV group was fed sucrose solution; the DG group was fed D-galactose solution; and the SB group was fed D-galactose and sodium butyrate solution. A comprehensive assessment was conducted on day 15 post-treatment, including survival analysis, starvation test, motor, learning and memory ability tests, malondialdehyde test, and Smurf test. Potential mechanisms through the microbiome and metabolome were investigated. Compared to the honeybees from the CV group, those in the DG group showed a shortened lifespan, a weaker energy storage ability, impaired motor, learning, and memory abilities, reduced weight, increased oxidation, and a disrupted gut barrier. These phenotypic changes were associated with microbial dysbiosis characterized by Lactobacillus enrichment and diminished butyrate levels. Notably, sodium butyrate supplementation extended the honeybees’ lifespan and improved their learning and memory abilities damaged by D-galactose. Our findings establish honeybees as a valuable model system for aging research and highlight the crucial role of butyrate metabolism in senescence regulation. IMPORTANCE: This study presents a novel approach to investigating aging processes by establishing a D-galactose-induced aging model in honeybees. Our findings demonstrate that butyrate supplementation effectively attenuates D-galactose-induced senescence phenotypes, suggesting its potential as a therapeutic intervention for age-related decline. This research provides a unique model system for aging studies and highlights the significant role of butyrate in modulating senescence progression. The results contribute to our understanding of the molecular mechanisms underlying aging and offer new insights into potential anti-aging strategies.